HealthMyne, an innovator in leveraging imaging data to empower Radiologists to move “Beyond Imaging”, will be unveiling and providing demonstrations of their new commercial platform at RSNA booth #4165 in the South Hall.
The Quantitative Imaging Decision Support (QIDS)™ software platform combines imaging data with electronic medical record, radiation therapy and other clinical systems information to provide clinical decision support in the primary read. Currently focused on Radiology and Oncology, with future expansion into other specialties, QIDS (pronounced ‘quids’) is uniquely designed to positively impact clinical productivity and prepares Radiologists for the transition to Value-Based Payment.
HealthMyne asserts that in order for Radiologists to extend their value as a member of the care team, highly curated evidence-based narratives, imaging analytics, and patient cohort analysis must be generated to provide clinical decision support in the primary read thereby enabling improved cancer diagnosis, staging and treatment.
“Our mission at HealthMyne is to support Radiology in its transition from a volume-based provider to a value-based quantitative imaging, analytics and point of care clinical decision support collaborative partner with multiple specialties starting with Oncology”, stated Arvind Subramanian, the CEO of HealthMyne. “We have developed a platform that allows Radiologists to meet this new paradigm by allowing them to add value to the equation while also increasing productivity.”
Attendees of RSNA who take part in a demonstration of the QIDS platform can simultaneously make a difference for children and adults living with cancer. For each demo given, HealthMyne will make a $25 donation to Gilda’s Club of Madison.
Attendees can come to booth #4165 in the South Hall to take part in a demo, or claim a desired time by signing up HERE.
For HealthMyne Contact: